Loratadine and Pseudoephedrine Articles
Schering-Plough settles Claritin-D patent litigation with Impax
3 November 2003
Aventis takes on US antihistamine market with once-daily Allegra
29 February 2000
Andrx files for generic Claritin in USA
29 February 2000
Fexofenadine Launched In Its First Market
2 September 1996
US Drug Cos Reveal Strong Growth In 1995 3rd Qtr
30 October 1995
Showing 1-5 of 5 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
